Editas Medicine Inc (EDIT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

11 HURLEY ST. CAMBRIDGE, MA 02141

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Data as of 2021-08-02 08:48:08 -0400
Market Cap2.839 Billion Shares Outstanding67.826 Million Avg 30-day Volume1.351 Million
P/E Ratio-21.03434 Dividend Yield EPS-2.2
Price/Sales31.03 Debt to Equity1.22 EBITDA-140.783 Million
Price to Book Value4.45 Forward PE-0.69 Enterprise Value2.484 Billion
Total Cash354.918 Million Current Debt64.01 Million Gross Profit91.508 Million
BETA1.65114 52-week High/Low99.95 / 27.01 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -67.2531
Data provided by IEX Cloud
View SEC Filings from EDIT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 301 302 -0.33% 73 (4.28%) 66 (3.83%) 10.61%
13F shares: 52.549 Million 52.95 Million -0.76% 21.208 Million 22.094 Million -4.01%
% Ownership 78.0096 84.9451 -8.16% 31.4838 35.4444 -11.17%
New Positions: 63 105 -40.0% 18 20 -10.0%
Increased Positions 114 82 39.02% 30 12 150.0%
Closed Positions 60 31 93.55% 11 10 10.0%
Reduced Positions 68 68 0.0% 14 24 -41.67%
Total Calls 2.442 Million 2.609 Million -6.4% 710.8 Thousand 464.3 Thousand 53.09%
Total Puts 1.776 Million 1.93 Million -7.95% 635.8 Thousand 289.7 Thousand 119.47%
PUT/CALL Ratio 0.73 0.74 -1.35% 0.89 0.62 43.55%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EDIT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EDIT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

2.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

2.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EATON BRUCE EVP, CHIEF BUSINESS OFFICER

  • Officer
28,313 2021-07-23 1

ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER

  • Officer
146,235 2021-06-28 3

MULLEN JAMES C CEO

  • Officer
  • Director
170,989 2021-06-14 2

SHEARMAN MARK S EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
85,419 2021-06-14 2

VAISHNAW AKSHAY

  • Director
11,538 2021-06-03 1

HIRSCH ANDREW

  • Director
11,538 2021-06-03 1

HOPFIELD JESSICA

  • Director
11,538 2021-06-03 2

SCADDEN DAVID

  • Director
11,538 2021-06-03 1

CHATTERJEE MEETA

  • Director
11,538 2021-06-03 3

COLLINS CYNTHIA CEO

  • Officer
43,760 2021-02-09 2

ALBRIGHT CHARLES EVP/CHIEF SCIENTIFIC OFFICER

  • Officer
24,907 2020-12-15 7

MICHAELS LISA ANNE EVP/CHIEF MEDICAL OFFICER

  • Officer
20,000 2020-11-09 2

ABRAMS JUDITH R CHIEF MEDICAL OFFICER

  • Officer
25,000 2019-10-28 0

MYER VICKESH CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-03-18 0

EK ERIC INTERIM CFO

  • Officer
0 2019-03-01 0

HACK ANDREW A. F. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-04 0

BOSLEY KATRINE PRESIDENT AND CEO

  • Officer
  • Director
1,204,966 2019-01-08 0

NIKOLIC BORIS

  • Director
0 2018-06-15 0

COX GERALD FRANK CHIEF MEDICAL OFFICER

  • Officer
0 2018-02-07 0

COLE DOUGLAS G.

  • Director
3,171 2017-08-17 0

BORISY ALEXIS

  • Director
0 2017-06-15 0

MENDLEIN JOHN

  • Director
0 2017-06-15 0

BITTERMAN KEVIN

  • Director
0 2017-06-15 0

GLUCKSMANN ALEXANDRA CHIEF OPERATING OFFICER

  • Officer
117,788 2017-03-15 0

POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.

POLARIS VENTURE PARTNERS VI, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.

  • 10% Owner
3,797,144 2016-12-07 0

STARR KEVIN P

  • 10% Owner
3,906,176 2016-09-06 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
3,906,176 2016-08-16 0

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2016-08-11 0

FLYNN JAMES E

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT HIF, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2016-02-08 0

BNG0, LLC

  • 10% Owner
No longer subject to file 2016-02-08 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SUNDHEIM DANIEL S.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2016-02-08 0

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING LONG FUND MASTER LTD.

VIKING LONG FUND GP LLC

  • 10% Owner
2,040,814 2016-02-08 0

ZHANG FENG

  • 10% Owner
480,769 2016-02-02 0

LIU DAVID R.

  • 10% Owner
480,769 2016-02-02 0

JOUNG J. KEITH

  • 10% Owner
480,769 2016-02-02 0

CHURCH GEORGE

  • 10% Owner
480,769 2016-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ROBERTSON MICHELLE - Officer CHIEF FINANCIAL OFFICER

2021-06-30 16:11:49 -0400 2021-06-28 M 2,500 d 117,500 direct yes

ROBERTSON MICHELLE - Officer CHIEF FINANCIAL OFFICER

2021-06-30 16:11:49 -0400 2021-06-28 S 2,500 $50.00 d 28,735 direct yes -2.8662 -14.0658 0.0 1 -19.1437 4

ROBERTSON MICHELLE - Officer CHIEF FINANCIAL OFFICER

2021-06-30 16:11:49 -0400 2021-06-28 M 2,500 $30.65 a 31,235 direct yes -2.8662 -14.0658 0.0 1 -19.1437 4

SHEARMAN MARK S - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-06-16 16:19:04 -0400 2021-06-14 A 32,701 a 32,701 direct -0.7743 13.0254 15.7633 56.6372 10 -0.7743 2

MULLEN JAMES C - Director - Officer CEO

2021-06-16 16:20:42 -0400 2021-06-14 A 170,989 a 170,989 direct

SHEARMAN MARK S - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-06-16 16:19:04 -0400 2021-06-14 A 52,718 a 52,718 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EDITAS MEDICINE INC EDIT 2021-08-05 22:15:04 UTC -0.2531 0.3331 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 21:45:03 UTC -0.2556 0.3356 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 21:15:03 UTC -0.2556 0.3356 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 20:45:03 UTC -0.2558 0.3358 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 20:15:04 UTC -0.2558 0.3358 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 19:45:04 UTC -0.2558 0.3358 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 19:15:03 UTC -0.2558 0.3358 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 18:45:03 UTC -0.2552 0.3352 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 18:15:03 UTC -0.2552 0.3352 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 17:45:03 UTC -0.2552 0.3352 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 17:15:03 UTC -0.2552 0.3352 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 16:45:02 UTC -0.2596 0.3396 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 16:15:03 UTC -0.2596 0.3396 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 15:45:03 UTC -0.2596 0.3396 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 15:15:02 UTC -0.2596 0.3396 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 14:45:02 UTC -0.2416 0.3216 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 14:15:04 UTC -0.2416 0.3216 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 13:45:04 UTC -0.2416 0.3216 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 13:15:03 UTC -0.2416 0.3216 1500000
EDITAS MEDICINE INC EDIT 2021-08-05 12:45:03 UTC -0.2416 0.3216 1500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund EDIT -134.0 shares, $-2657.22 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund EDIT -93.0 shares, $-1844.19 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund EDIT -154.0 shares, $-3053.82 2020-03-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund EDIT -40.0 shares, $-1680.0 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund EDIT -1000.0 shares, $-42000.0 2021-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio EDIT -5100.0 shares, $-214200.0 2021-03-31 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund EDIT -1156.0 shares, $-42783.56 2021-04-30 N-PORT

Elevate your investments